A High‐Throughput Platform Utilizing FPBG‐PITC for Amino‐Containing Metabolites Screening in Breast Diseases
Small Methods · 2025
DOI: 10.1002/smtd.202500297 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, 2025. Verfasst von Hongtao Tian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics and Structural Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine,…. Hauptthemen laut MEDLINE: High-Throughput Screening Assays, Breast Neoplasms, Metabolomics, Breast Diseases. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Medical Sciences Initiative for Innovative Medicine.
Abstract (Originalsprache)
Amino‐containing metabolites play essential roles in biological processes such as protein synthesis and energy metabolism, and their dysregulation is associated with disease development. Liquid biopsy, valued for its minimal invasiveness, is widely utilized in cancer detection. However, traditional methods necessitate protein and lipid removal while suffering from low throughput and sensitivity. To address these limitations, a novel magnetic chemoselective probe, Fe 3 O 4 ‐Polymers‐Cystamine‐Boclys‐Gly‐NH 2 ‐PITC (FPBG‐PITC), is synthesized, incorporating hydrophobic tags to improve metabolite detection sensitivity and chromatographic separation. Using this probe, a high‐throughput metabolic analysis platform is established, allowing efficient enrichment, purification, and quantification of serum amino‐containing metabolites with reduced costs. Through comparative analysis of serum samples from healthy controls and patients with benign or malignant breast lesions, four metabolites—asparagine, tryptophan, leucine/isoleucine, and homocitrulline—are identified as potential biomarkers for early breast disease screening, providing a novel diagnostic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biophysics and Structural Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China.
- Department of Biomedical Engineering, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China.
- Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China.
- Analytical Instrumentation Center, College of Chemistry and Molecular Engineering, Peking University, Beijing, 100871, China.
ORCID-Profile: Jiang Zhou, Zhili Li
Förderung
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
Zitieren
APA
Tian, H., Zhang, W., Chen, Y., Zhao, R. C., Zhou, J., & Li, Z. (2025). A High‐Throughput Platform Utilizing FPBG‐PITC for Amino‐Containing Metabolites Screening in Breast Diseases. Small Methods. https://doi.org/10.1002/smtd.202500297
Vancouver
Tian H, Zhang W, Chen Y, Zhao RC, Zhou J, Li Z. A High‐Throughput Platform Utilizing FPBG‐PITC for Amino‐Containing Metabolites Screening in Breast Diseases. Small Methods. 2025. doi:10.1002/smtd.202500297
BibTeX
@article{Tian2025,
author = {Tian, Hongtao and Zhang, Wenjia and Chen, Yunhua and Zhao, Robert Chunhua and Zhou, Jiang and Li, Zhili},
title = {A High‐Throughput Platform Utilizing FPBG‐PITC for Amino‐Containing Metabolites Screening in Breast Diseases},
journal = {Small Methods},
year = {2025},
doi = {10.1002/smtd.202500297}
}
EUVIMED